Skip to main content
. 2019 Nov 8;318(1):H11–H24. doi: 10.1152/ajpheart.00325.2019

Fig. 9.

Fig. 9.

Coronary blood flow (A), myocardial oxygen consumption (B), and coronary venous Po2 (C) at rest and during exercise in the absence and presence of the KV channel inhibitor 4-aminopyridine (4-AP) in conscious instrumented swine. Data from Berwick et al. (10). *P < 0.05 vs. control.